The timing of venous thromboembolic events after spine surgery: A single-center experience with 6869 consecutive patients

Michael B. Cloney, Benjamin Hopkins, Ekamjeet S. Dhillon, Nader S. Dahdaleh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


OBJECTIVE Venous thromboembolic events (VTEs), including both deep venous thrombosis (DVT) and pulmonary embolism, are a major cause of morbidity and mortality after spine surgery. Prophylactic anticoagulation, or chemoprophylaxis, can prevent VTE. However, the timing of VTEs after spine surgery and the effect of chemoprophylaxis on VTE timing remain underinvestigated. METHODS The records of 6869 consecutive spine surgeries were retrospectively examined. Data on patient demographics, surgical variables, hospital course, and timing of VTEs were collected. Patients who received chemoprophylaxis were compared with those who did not. Appropriate regression models were used to examine selection for chemoprophylaxis and the timing of VTEs. RESULTS Age (OR 1.037, 95% CI 1.023-1.aaaaaaaa051p <0.001), longer surgery (OR 1.003, 95% CI 1.002-1.004p <0.001), history of DVT (OR 1.697, 95% CI 1.038-2.776,p = 0.035), and fusion surgery (OR 1.917, 95% CI 1.356-2.709p <0.001) predicted selection for chemoprophylaxis. Chemoprophylaxis patients experienced more VTEs (3.62% vs 2.03% of patients, respectivelyp <0.001), and also required longer hospital stays (5.0 days vs 1.0 days HR 0.5107p <0.0001) and had a greater time to the occurrence of VTE (median 6.8 days vs 3.6 days HR 0.6847 p = 0.0003). The cumulative incidence of VTEs correlated with the postoperative day in both groups (Spearman r = 0.9746, 95% CI 0.9457-0.9883, and p <0.0001 for the chemoprophylaxis group Spearman r = 0.9061, 95% CI 0.8065-0.9557, and p <0.0001 for the nonchemoprophylaxis group), and the cumulative incidence of VTEs was higher in the nonchemoprophylaxis group throughout the 30-day postoperative period. Cumulative VTE incidence and postoperative day were linearly correlated in the frst 2 postoperative weeks (R = 0.9396 and p <0.0001 for the chemoprophylaxis group R = 0.8190 and p = 0.0003 for the nonchemoprophylaxis group) and the remainder of the 30-day postoperative period (R = 0.9535 and p <0.0001 for the chemoprophylaxis group R = 0.6562 and p = 0.0058 for the nonchemoprophylaxis group), but the linear relationships differ between these 2 postoperative periods (p <0.0001 for both groups). CONCLUSIONS Anticoagulation reduces the cumulative incidence of VTE after spine surgery. The cumulative incidence of VTEs rises linearly in the frst 2 postoperative weeks and then plateaus. Surgeons should consider early initiation of chemoprophylaxis for patients undergoing spine surgery.

Original languageEnglish (US)
Pages (from-to)88-95
Number of pages8
JournalJournal of Neurosurgery: Spine
Issue number1
StatePublished - Jan 2018


  • Anticoagulation
  • Chemoprophylaxis
  • DVT
  • Deep vein thrombosis
  • Pulmonary embolism
  • Spine surgery
  • Vascular disorders
  • Venous thromboembolism

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'The timing of venous thromboembolic events after spine surgery: A single-center experience with 6869 consecutive patients'. Together they form a unique fingerprint.

Cite this